(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.(b)(4).The device was received.The investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
|
Internal file number (b)(4).Evaluation summary: a visual and dimensional inspection was performed on the returned device.The reported dislodgement was confirmed during visual inspection.It should be noted that the xience sierra everolimus eluting coronary stent system instruction for use (ifu), the following is stated: prior to using the xience sierra stent system, carefully remove the system from the package and inspect for bends, kinks and other damage.Verify that the stent does not extend beyond the radiopaque balloon markers.Do not use if any defects are noted.In this case, the ifu deviation did not contribute to the reported stent dislodgement.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.The investigation determined the reported dislodgement appears to be related to operational context as it is likely that inadvertent mishandling during protective sheath removal resulted in the reported stent dislodgment.There is no indication of a product quality issue with respect to design, manufacture or labeling.
|